14 hours ago

4 Jun 2020 In addition to SCO-101 the Company has two other drug candidates, SCO-201 and SCO-301. Scandion Oncology was listed on Spotlight Stock

Access detailed information about the Scandion Oncology A/S (SCOLG) Share including Price, Charts, Technical Analysis, Historical data, Scandion Oncology Reports and more. Bakgrund Scandion Oncology är ett bioteknikbolag grundat 2017 i syfte att angripa en av de största utmaningarna inom modern onkologi – behandling av cancer som innehåller läkemedelsresistenta cellkloner eller som har utvecklat resistens mot ett tidigare givet cancerläkemedel. Immediately thereafter, Scandion Oncology’s Chairman of the Board, Dr. Peter Høngaard Andersen bought an additional 6000 shares in Scandion Oncology resulting in a total holding on 37,839 shares – corresponding to a monetary value of approximately 1.65 million SEK – a strong show of faith and confidence in the company’s vision, technology and team. It includes services to send our press releases (Cision), news agency distribution (Ritzau) and analysts’ coverage (Affärsvärlden).

Knowing exactly what drives relative strength in share prices can help you find profitable trades based on momentum – and Scandion Oncology A/s might just fit the bill. Exercise price: Each warrant entitles the holder the right to subscribe for one (1) new share in Scandion Oncology at a subscription price of SEK 5.20 per share. Issue volume: If the initial issue of units is fully subscribed, a total of 2 381 530 warrants of series TO 1 will be issued. SCANDION ONCOLOGY A/S : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share SCANDION ONCOLOGY A/S | Nasdaq Stockholm: SCOL | Nasdaq Stockholm 2020-06-16 10:30:54 Scandion Oncology A/S: Scandion Oncology has received a Eurostars grant of 800,000 EUR, shared with Erasmus Medical Centre, Rotterdam and 2cureX AB, for evaluating SCO-101 against antiestrogen resistance in breast cancer +12,32% | 13,5 MSEK Scandion Oncology is within an approximate horizon This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

1720681D Stock Quote - Scandion Oncology A/S - Bloomberg Markets.

Find price information for Nordic shares, indexes, bonds, options, futures and on 2021-02-03 08:30:00, Nasdaq Stockholm Welcomes Scandion Oncology to

Share price. 20.2.

Price trends tend to persist, so it's worth looking at them when it comes to a share like Scandion Oncology A/S. Over the past six months, the relative strength of its shares against the market has been %. At the current price of SEK0.001, shares in Scandion Oncology A/S are trading at % against their 200 day moving

aktien på Nasdaq First North, samtidigt som den avnoteras på Spotlight Stock Market. Sanionas spin-out Scandion Oncology får godkännande att noteras på Spotlight Stock Market.

SCOL, Scandion Oncology, (DK0061031895) Trading; Note that the company may have other share series Scandion Oncology A/s share price hits a one-year high. Shares in Scandion Oncology A/s ( AKT:SCOL) are currently trading close to a 52 week high, with the share price up by around 29.3% to 72 over Investor overview Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have developed resistance to chemotherapy. What makes Scandion Oncology an attractive company for investors? Limited investment horizon: Clinical Phase II studies will be completed within few years after investment. Potential high return: Detailed Price (SEK) 20.20; Today's Change 0.50 / 2.54%; Shares traded 135.47k; 1 Year change +23.24%; Beta-- Historical prices; Other instruments Trade Reports . SCOL, Scandion Oncology, (DK0061031895) Trading; Note that the company may have other share series Scandion Oncology A/S Ordinary Shares SCOL Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Per Share Data Scandion Oncology A/S All values updated annually at fiscal year end. Earnings Per Share-1.17: with the exception of the current price and price history, was supplied by Lipper, At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life.
Barnets starka sidor

Projektet kommer ursprungligen från danska Neurosearch som för flera år sedan sålde ut delar av sin verksamhet. Scandion genomför nu en nyemission på 26 Mkr inför listning på Spotlight The Board of Directors in Scandion Oncology A/S (”Scandion Oncology” or the ”Company”) has today, 16 November 2020, pursuant to the authorization granted by the extraordinary general meeting on 13 November 2020, resolved on a fully guaranteed new share issue of 10,711,848 shares with preferential rights for the Company’s existing shareholders (the ”Rights Issue”).

3,932.37. NASDAQ. 13,251.11.
Vad händer i eksjö idag

timeedit lokalbokning
vafan colo
malena ivarsson naken
pågående rekonstruktioner
sök med chassinummer

Vator Securities advises Scandion Oncology on 236 MSEK Rights Issue better response rates and increased survival time with improved quality of life. of SEK 100 per share, corresponding to an equity value of approximately SEK 6.6 bn

The purchase price for each share in Scandion Oncology will be the volume weighted average price of the Company’s shares on Spotlight Stock Market during a period of ten (10) trading days after the publication of this press release with ten (10) percent discount. For further information regarding Scandion Oncology, please contact: Latest Scandion Oncology A/S (SCOL:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.